Press Releases Year None2021202020192018201720162015201420132012201120102009 Date Title Views Aug 20, 2021 Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version View HTML Aug 09, 2021 Epizyme Announces CEO Succession PDF Version View HTML Aug 09, 2021 Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update PDF Version View HTML Aug 08, 2021 Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China PDF Version View HTML Aug 03, 2021 Epizyme Announces Date of Second Quarter 2021 Financial Results PDF Version View HTML Jun 16, 2021 Epizyme Launches EZH2Now Testing Program with Quest Diagnostics for Relapsed or Refractory Follicular Lymphoma Patients PDF Version View HTML May 25, 2021 Epizyme to Participate in Jefferies Virtual Healthcare Conference PDF Version View HTML May 12, 2021 Epizyme Announces Preclinical and Clinical Data to be Presented in Oral and Poster Sessions at Upcoming Medical Conferences in June PDF Version View HTML May 06, 2021 Epizyme Provides Business Update and Reports First Quarter 2021 Financial Results PDF Version View HTML Apr 29, 2021 Epizyme Announces Date of First Quarter 2021 Financial Results PDF Version View HTML Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Next page next › Last page last »
